KR100204697B1 - 트리아졸릴 치환된 3급 아민 화합물 또는 이의 염 - Google Patents

트리아졸릴 치환된 3급 아민 화합물 또는 이의 염 Download PDF

Info

Publication number
KR100204697B1
KR100204697B1 KR1019940700682A KR19940700682A KR100204697B1 KR 100204697 B1 KR100204697 B1 KR 100204697B1 KR 1019940700682 A KR1019940700682 A KR 1019940700682A KR 19940700682 A KR19940700682 A KR 19940700682A KR 100204697 B1 KR100204697 B1 KR 100204697B1
Authority
KR
South Korea
Prior art keywords
group
amino
triazole
compound
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019940700682A
Other languages
English (en)
Korean (ko)
Inventor
오카다미노루
가와미나미에이지
요덴도루
구도마사후미
이소무라야스오
Original Assignee
오노다 마사요시
야마노우치세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오노다 마사요시, 야마노우치세이야쿠 가부시키가이샤 filed Critical 오노다 마사요시
Application granted granted Critical
Publication of KR100204697B1 publication Critical patent/KR100204697B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Cosmetics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
KR1019940700682A 1991-09-02 1992-08-27 트리아졸릴 치환된 3급 아민 화합물 또는 이의 염 Expired - Fee Related KR100204697B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP24826891 1991-09-02
JP91-248268 1991-09-02
JP34401191 1991-12-02
JP91-344011 1991-12-02
PCT/JP1992/001089 WO1993005027A1 (fr) 1991-09-02 1992-08-27 Amine tertiaire triazolylee ou un sel de celle-ci

Publications (1)

Publication Number Publication Date
KR100204697B1 true KR100204697B1 (ko) 1999-06-15

Family

ID=26538684

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940700682A Expired - Fee Related KR100204697B1 (ko) 1991-09-02 1992-08-27 트리아졸릴 치환된 3급 아민 화합물 또는 이의 염

Country Status (20)

Country Link
US (1) US5674886A (enExample)
EP (1) EP0641785B1 (enExample)
KR (1) KR100204697B1 (enExample)
CN (1) CN1035817C (enExample)
AT (1) ATE186052T1 (enExample)
AU (1) AU665569B2 (enExample)
BG (1) BG61688B1 (enExample)
CA (1) CA2116773C (enExample)
DE (1) DE69230225T2 (enExample)
ES (1) ES2139605T3 (enExample)
FI (1) FI940988L (enExample)
HU (1) HU220863B1 (enExample)
MX (1) MX9204996A (enExample)
NO (1) NO305284B1 (enExample)
PT (1) PT100821B (enExample)
RO (1) RO114129B1 (enExample)
RU (1) RU2124010C1 (enExample)
TW (1) TW225526B (enExample)
UA (1) UA41295C2 (enExample)
WO (1) WO1993005027A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
RU2131422C1 (ru) * 1997-05-21 1999-06-10 Иван Антонович Мазур Бромид 1-пентил-4-(п-метоксибензилиденамино)-1,2,4-триазолия, проявляющий спазмолитическую активность
US7022702B2 (en) * 2000-04-07 2006-04-04 Qlt Inc. Antiproliferative 1,2,3-thiadiazole compounds
US6420400B1 (en) 2000-04-07 2002-07-16 Kinetek Pharmaceuticals, Inc. Antiproliferative 1,2,3-thiadiazole compounds
IL156584A0 (en) * 2000-12-22 2004-01-04 Ortho Mcneil Pharm Inc Substituted triazole diamine derivatives as kinase inhibitors
GB0120147D0 (en) * 2001-08-17 2001-10-10 Metris Therapeutics Ltd Treatment method
GB0127923D0 (en) 2001-11-21 2002-01-16 Sterix Ltd Compound
WO2003045925A1 (en) * 2001-11-21 2003-06-05 Sterix Limited 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
JP2004196795A (ja) * 2002-12-16 2004-07-15 Wyeth 外部寄生虫駆除剤としてのｎ−フェニル−３−シクロプロピルピラゾール−４−カルボニトリル
EP1431292A1 (en) * 2002-12-16 2004-06-23 Laboratoire Theramex 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors
AU2011226950B9 (en) * 2003-12-15 2013-04-11 Laboratoire Theramex 1-N-phenyl-amino-1H-imidazole derivatives and pharmaceutical compositions containing them
US8476455B2 (en) 2003-12-15 2013-07-02 Laboratoire Theramex 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
EP1544195A1 (en) * 2003-12-15 2005-06-22 Laboratoire Theramex 1-N-phenyl-amino- 1H-imidazole derivatives and pharmaceutical compositions containing them
GB0411562D0 (en) * 2004-05-24 2004-06-23 Sterix Ltd Compound
JP5777163B2 (ja) * 2009-07-03 2015-09-09 国立研究開発法人理化学研究所 Ｐｅｔ用標識化合物
GB0914767D0 (en) * 2009-08-24 2009-09-30 Sterix Ltd Compound
CN113387894B (zh) * 2021-06-22 2023-02-24 首都医科大学脑重大疾病研究中心(北京脑重大疾病研究院) 1-n-苯乙腈基氨基-三氮唑和嘧啶衍生物及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2488891A1 (fr) * 1980-08-22 1982-02-26 Roussel Uclaf Nouveaux derives du 4h-1,2,4-triazole, leur procede de preparation et leur application comme medicament
DE3410700A1 (de) * 1984-03-23 1985-09-26 Basf Ag, 6700 Ludwigshafen 2,4,5-triphenyl-v-triazole und deren verwendung
US4602025A (en) * 1984-06-18 1986-07-22 Eli Lilly And Company Aromatase inhibitors
US4609666A (en) * 1984-06-18 1986-09-02 Eli Lilly And Company Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
US4661508A (en) * 1984-06-18 1987-04-28 Eli Lilly And Company Aromatase inhibiting α,α-diphenyl-4(5)imidazole-methanes or -ethanes
US4749713A (en) 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
CH677925A5 (enExample) * 1986-12-03 1991-07-15 Sandoz Ag
US5041458A (en) * 1987-03-20 1991-08-20 E. I. Du Pont De Nemours And Company Fungicidal aminotriazoles and aminoimidazoles
EP0349580B1 (en) * 1987-03-20 1991-05-15 E.I. Du Pont De Nemours And Company Fungicidal aminotriazoles and aminoimidazoles
NZ224714A (en) * 1987-06-01 1990-03-27 Janssen Pharmaceutica Nv Substituted benzotriazole derivatives and pharmaceutical compositions
US4806554A (en) * 1988-01-11 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. Pyrazol and indazolpyridinamines
GR900100380A (el) * 1989-05-20 1991-10-10 Fisons Plc Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.

Also Published As

Publication number Publication date
FI940988A7 (fi) 1994-04-05
ES2139605T3 (es) 2000-02-16
BG61688B1 (bg) 1998-03-31
CA2116773C (en) 2002-12-10
FI940988A0 (fi) 1994-03-02
AU665569B2 (en) 1996-01-11
DE69230225T2 (de) 2000-05-31
ATE186052T1 (de) 1999-11-15
FI940988L (fi) 1994-04-05
RO114129B1 (ro) 1999-01-29
HU9400611D0 (en) 1994-09-28
CN1035817C (zh) 1997-09-10
EP0641785A4 (en) 1994-06-16
US5674886A (en) 1997-10-07
CN1069974A (zh) 1993-03-17
NO940686D0 (no) 1994-02-28
AU2487492A (en) 1993-04-05
PT100821B (pt) 1999-07-30
EP0641785A1 (en) 1995-03-08
PT100821A (pt) 1993-11-30
BG98618A (bg) 1995-03-31
EP0641785B1 (en) 1999-10-27
CA2116773A1 (en) 1993-03-18
DE69230225D1 (de) 1999-12-02
RU2124010C1 (ru) 1998-12-27
MX9204996A (es) 1993-08-01
TW225526B (enExample) 1994-06-21
HU220863B1 (en) 2002-06-29
NO305284B1 (no) 1999-05-03
NO940686L (enExample) 1994-04-29
HUT67249A (en) 1995-03-28
WO1993005027A1 (fr) 1993-03-18
UA41295C2 (uk) 2001-09-17

Similar Documents

Publication Publication Date Title
KR100204697B1 (ko) 트리아졸릴 치환된 3급 아민 화합물 또는 이의 염
US5371100A (en) Optically active tetrazole compounds, and fungicidal compositions thereof
DE69728673T2 (de) Substituierte biphenylisoxazolsulfonamide
EP0567982B1 (en) Azole compounds, their production and use
KR870001167B1 (ko) 치환된 2-(1h)-퀴놀론의 제조방법
EP0456835B1 (en) Quinazoline-3-alkanoic acid derivative, salt thereof, and production thereof
EP0702012A1 (en) Substituted isoxazole sulfonamides and their use as endothelin antagonists
KR0163624B1 (ko) 신규의 치환된 3급 아미노 화합물 또는 이의 염
KR20010101730A (ko) 매트릭스 금속단백질분해효소 억제제로서의2,3,4,5-테트라하이드로-1에이치-[1,4]벤조디아제핀-3-하이드록삼산
HU217907B (hu) Kinolin- vagy kinazolinszármazékok, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények
JPWO1993022290A1 (ja) 新規置換３級アミノ化合物又はその塩
HUP0100277A2 (hu) 2,3,4,5-Tetrahidro-1H-[1,4]benzodiazepin-3-hidroxámsav-származékok mint metalloproteináz inhibitorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
US5120749A (en) Platelet activating antagonists
CA1317948C (en) Omega-¬(hetero)alkyl|benz¬cd|-indol-2-amines
US5389663A (en) 1-(1h-1,2,4-triazole-yl)-2-propanol compounds
JP2500849B2 (ja) トリアゾリル置換３級アミノ化合物又はその塩
US6943183B2 (en) 5-substituted tetralones as inhibitors of ras farnesyl transferase
JPWO1993005027A1 (ja) トリアゾリル置換３級アミノ化合物又はその塩
US4269774A (en) Thiazolo[5,4-d][2]benzazepines
WO2003031437A1 (en) Propylcarbamate derivatives as inhibitors of serine and cysteine proteases
US4321199A (en) Thiazolo[5,4-d][2] benzazepines and intermediates
EP0897920A1 (en) Novel heterocyclic compounds having platelet aggregation inhibitory effects
HK1014709A (en) Substituted isoxazole sulfonamides and their use as endothelin antagonists
JPH07228574A (ja) 光学活性アゾール誘導体、その製造方法及び用途
JPH0633255B2 (ja) テトラヒドロキノリン誘導体

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20030319

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20040331

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20040331

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000